Adam Jones
I have been writing for Market Realist since 2014. I currently cover the cannabis sector, and I was drawn to the cannabis industry almost two years ago, when it was just emerging. I was fascinated by the variety of applications this single plant can have.
In addition, I like to explore different industries and am particularly interested in discovering good stocks. In the past, I've also covered the agricultural fertilizer and restaurant sectors.
When I'm not writing for Market Realist, I love reading books based on real-life events. I also enjoy reading biographies of people who have inspired the world in some way.
Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.
More From Adam Jones
IIPR: How to Invest in Cannabis and Still Make Money
While cannabis investors lost a lot of wealth last year, one stock continued to deliver staggering returns—Innovative Industrial Properties (IIPR).
Is it Too Much Marijuana Capacity or Too Little Demand?
The cannabis industry is struggling. Marijuana company executives blame overcapacity and lack of demand for poor results.
Why Is CannTrust Experiencing a Rally in 2020?
CannTrust (CTST) stock has experienced a surprising turn of events in January. The stock has gained good upward momentum.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Cannabis Pullback Might Benefit Some Companies and Investors
Most cannabis investors weren’t particularly happy in 2019. The small rally December 31 was driven more by sentiment than pure fundamentals.
Sales Drivers and What to Expect for Fertilizer Companies
The world has a problem that’s actually good for the fertilizer industry. This is the world’s population, which is ever-growing, as is food consumption.
Why Medical Cannabis Lacks Scientific History
Legal cannabis for medical purposes has been available for several years, yet you’ll often hear people say that cannabis lacks science.
CannTrust Receives NYSE Listing Compliance Notice
Beleaguered cannabis company CannTrust (CTST)(TRST) received a notice from the NYSE that the company is no longer in compliance with its listing rules.
Vaping Products Will Remain Part of Cannabis 2.0
Several cannabis producers in Canada are continuing to produce products for vaping in anticipation of Cannabis 2.0 demand.
FDA on Cannabis: The Positives and Negatives
The FDA has a huge impact on cannabis-related businesses in the US. Cannabis is already illegal, and the FDA creates more challenges for cannabis companies.
Why OrganiGram’s Recent Equity Program Is Bad News
On Wednesday, OrganiGram (OGI) (OGI.TO) announced an equity program. Broadly, we think that the program is bad news for investors.
Why Republicans Don’t Push for Cannabis Legalization
Marijuana legalization in the US remains in limbo. Most Democrats have endorsed marijuana legalization. However, Republicans have yet to embrace it fully.
Charlotte’s Web Lawsuit: How Can It Impact Investors?
Charlotte’s Web Holdings (CWEB) (CWBHF) is one of the latest cannabis companies to be served with a class-action lawsuit.
OrganiGram’s Disappointing Q4 Earnings: Hope for Investors?
OrganiGram reported its fourth-quarter earnings last week. The company’s balance sheet saw an increase in its PPE to 219 million Canadian dollars.
The Illegal Cannabis Market Needs Tougher Competition
The cannabis industry has hit a bottom with most cannabis stocks trading at their 52-week low. The illegal cannabis market is only adding to the problem.
Will CBD Cosmetics Products Lift Cronos Group?
Cronos Group’s position in the CBD cosmetics market could be beneficial. The company is an established player in the market with the potential to grow 31%.
CannTrust Lands in Hot Water Again
The Canadian cannabis company CannTrust (CTST) announced that the Toronto Stock Exchange is reviewing the company’s listing.
Cronos Group’s Q3 Financials Were a Bit of a Letdown
Cronos Group (CRON) released its latest quarterly financial statements, and investors should pay attention to a couple concerning items.
Michael Bloomberg for 2020: Will He Legalize Cannabis?
The cannabis market remains a priority for many voters—not just investors. But Michael Bloomberg, presidential hopeful, is not pro-cannabis.
Cannabis Industry Needs Retail and Social Engagement
The cannabis sector has entered bearish territory, with a weak earnings season raising doubts about the industry’s future. What could help the sector?
ACB Adds to Its Management Team: Why Now?
Aurora Cannabis (ACB) recently named Shane Morris as its new Chief Product Officer. André Jérôme was named ACB’s Chief Integration Officer.
Bank of America Upgrades Canopy Growth to ‘Buy’
Canopy Growth (WEED)(CGC) got a rare upgrade to “buy” from Bank of America today. Find out what drove the change—and what’s next.
Illegal Cannabis: A Big Problem for Legal Producers
Despite Canada’s legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.
Did HEXO Get Itself into a Licensing Scandal?
Last week, HEXO Corporation (HEXO) issued a press release that provided more information about its Niagara facility license.
Cannabis Sector: The Worst Isn’t Over
The cannabis sector is running high on negative sentiment after two of its biggest players reported disappointing earnings on November 14.
Cannabis Aurora Cannabis’s Earnings Coming after Hours
Aurora Cannabis (ACB)(ACB.TO) plans to announce its earnings after the market closes. However, its stock is already trading on a weak note.
Cannabis Cannabis Players are Looking at Consumer Goods
Cannabis companies are having problems in earning profits quickly. It’s becoming clear that the industry is facing challenges from illegal market products.
Cannabis Cannabis Sector: Five Reasons Investors Are on Edge
Four cannabis companies are set to release their earnings results this week, and investors seem worried. Let’s take a look at why.
Cannabis Hemp Farming in the US: What’s the Latest?
Hemp was legalized in the US last year as part of the Farm Bill of 2018. Let’s see how this crop has turned out for hemp farmers.
Cannabis Second Cup Coffee: Changing Cannabis Culture
Second Cup. Ltd (SCUPF) announced today that it’s changing its company structure. In addition, the company plans to change its strategy. Essentially, the company will change its name to Aegis Brands. Under the new structure, Aegis Brands will own the Second Cup brand. In addition, the brand portfolio will include other cannabis and food business. […]
Cannabis What’s Aurora Cannabis Short Interest Telling Us?
Aurora Cannabis (ACB) is one of the most closely watched cannabis players. Currently, the stock’s momentum is on a declining trend. Usually, when investors are pessimistic about a stock’s future, they sell their positions. However, there are investors that can make money without owning the stock. This process is known as shorting the stock. How […]
Cannabis Earnings: Top Three Things to Consider
Next week, several top cannabis companies are reporting their earnings results. Here’s what to watch for if you’re an investor.
Why CannTrust Is on a Long Road to Recovery
CannTrust (CTST) stock is gradually recovering after it hit an all-time low of $0.82 last month. However, the worst for the company isn’t over yet.
Medical Cannabis for Heart and Blood Pressure Patients
Medical cannabis is gaining widespread acceptance due to increased awareness. Notably, several countries are looking into cannabis as an alternative for existing medicine. So, Tilray expects about 40–80 countries to legalize medical cannabis over the next two or three years. To learn more, read Tilray’s Stock Price Is Subdued Despite Global Opportunities. [stock_market_widget type=”inline-label” template=”basic” […]
Vaping: What the CDC Has Uncovered So Far
Vaping-related illness has become the latest thorn in the cannabis industry’s side, and the issue could not have come up at a worse time.
Cannabis Sector: A Week in Review for September 27
Last week, ending on September 27, the cannabis sector was weighed down by the bears. Sector ETFs broadly ended the week in negative territory.
Marijuana Legalization: House Passes SAFE Act in US
Yesterday, the House passed the Secure and Fair Enforcement Banking Act, which aims to reduce cash transactions for legitimate marijuana businesses.
CannTrust Stock Hits an All Time Low: What’s Next?
CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.
Cannabis Marijuana Legalization Continues: Wisconsin Steps Up!
Marijuana laws are pretty strict in Wisconsin. Although cannabis is spreading its roots across US states, it’s still illegal at the federal level. President Trump and his administration want states to decide. Florida, New York, and Minnesota are all gearing up to legalize adult-use cannabis. Now, Wisconsin is pushing to legalize medical marijuana. Let’s see […]
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Vaping-Related Deaths: Anxiety Rises for Cannabis Stocks
Vaping has become a burgeoning health concern, as the seventh vaping-related death recently occurred in California. How are cannabis companies affected?
CannTrust Loses License: Will It Fall below $1?
CannTrust reported that its license under the Cannabis Act was suspended. The company won’t be able to produce cannabis. Will CannTrust fall below $1?.
Cannabis Legalization: Will Mexico Beat the US?
Cannabis regulation in Mexico is a key topic this week. The US, Canadian, and Mexican economies are more closely intertwined than other countries.
Marijuana Legalization: ‘Make It Legal Florida!’
Marijuana legalization is firing up. Currently, cannabis is legal for recreational use in ten states and Washington DC. Cannabis is legal for medical use in 33 states. Other states are also gearing up to legalize marijuana. Today, we’ll discuss how Florida is stepping up for cannabis legalization. “Make it legal, Florida!” Legalizing medical marijuana has […]
Cannabis Recreational Cannabis: How Is Michigan Shaping Up?
Michigan is one of the 11 states in the US that have legalized recreational or adult-use cannabis. In November 2018, Michigan residents voted in favor of legalizing recreational marijuana and created the MRTMA (Michigan Regulation and Taxation of Marihuana Act). LARA (the Michigan Department of Regulatory Affairs) was given the task of developing and enforcing […]
Cannabis Marijuana Legalization: Minnesota Welcomes You!
Marijuana legalization is an ongoing issue in the US. Currently, the District of Columbia and 11 states have legalized cannabis. Marijuana is still illegal for recreational use in Minnesota. However, the state’s voters might favor legalization. Minnesota voters are ready for marijuana legalization Minnesota hasn’t been able to come up with a legalization decision yet. […]
CannTrust: The Bad News Keeps Pouring In
CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive
Canopy Growth Rises on News of Key Extraction License
Canopy Growth (WEED)(CGC) was trading 3% higher early this morning after it announced the receipt of a key extraction license.
MedMen Launches Cannabis Delivery Service in the US
MedMen (MMNFF) closed almost 6% higher on Monday. The company announced the launch of its new California-wide delivery service for cannabis.
Canopy Growth Falls to Its Lowest Point in 2019
Today, Canopy Growth (WEED) (CGC) stock saw its lowest point in 2019. The stock opened at $28.3 but fell to $26.5 in the afternoon.
